
16,250 Ervebo Doses Arrive in DRC Amid Deadliest Ebola Outbreak
The story in brief
More than 16,250 doses of the Ervebo vaccine arrived in the Democratic Republic of Congo on Friday, part of a total 70,000 doses announced by the WHO. The vaccine, developed by Merck, is approved for the Zaire strain but not the Bundibugyo strain currently circulating. A clinical trial is underway to assess its effectiveness against the Bundibugyo strain, as the DRC faces its deadliest Ebola outbreak with over 2,516 deaths reported.